Stocks breaking to new annual highs
S&P 500 oversold value screener
Relative strength momentum leaders
Upcoming earnings dates & reports
Filter and sort all 500 stocks
Continuous multi-factor scoring & catalyst forensics
Today's biggest gainers and losers
Jacques Bogart S.A. is a French fragrance and cosmetics company operating primarily in Europe, with a portfolio of licensed designer brands (Carven, Ted Lapidus) and proprietary labels. The company faces structural headwinds with declining revenue (-1.3% YoY), negative net margins (-0.2%), and significant balance sheet stress (D/E 3.39x), reflected in a 41% stock decline over 12 months. Trading at 0.2x sales suggests deep value or distress, with the market pricing in execution risk and competitive pressure from LVMH, L'Oréal, and Estée Lauder in the fragmented European beauty market.
Jacques Bogart generates revenue through licensing agreements with fashion houses to manufacture and distribute fragrances, capturing margin on production scale and distribution networks primarily across French pharmacies, perfumeries, and European retail channels. The 52.8% gross margin reflects manufacturing efficiency, but the 3.0% operating margin indicates high SG&A burden from marketing, licensing fees, and distribution costs. Pricing power is limited in the mass-premium segment, with competition forcing promotional activity. The business model depends on license renewal negotiations and maintaining shelf space in fragmented European retail, where direct-to-consumer brands are gaining share.
License agreement renewals or losses with key fashion brands - critical for revenue stability
European retail traffic trends and perfumery same-store sales - primary distribution channel performance
Gross margin trajectory driven by raw material costs (alcohol, oils) and promotional intensity
Debt refinancing announcements given 3.39x leverage and negative cash generation
Market share shifts in French pharmacy/perfumery channels versus LVMH Selective Retailing and independent chains
Direct-to-consumer fragrance brands (Glossier, Byredo, Le Labo) bypassing traditional retail and capturing younger demographics with digital-native marketing, eroding pharmacy/perfumery traffic
Consolidation in European retail (Sephora expansion, Douglas restructuring) reducing negotiating leverage for mid-tier brands and increasing slotting fees
Sustainability regulations in EU cosmetics (ingredient restrictions, packaging mandates) requiring reformulation capex and potential SKU rationalization
LVMH, L'Oréal Luxe, and Estée Lauder dominating prestige fragrance with superior marketing budgets and celebrity partnerships, squeezing shelf space for licensed mid-tier brands
Private label fragrance growth in European supermarkets and discounters offering 40-60% price discounts, pressuring volume in Jacques Bogart's core mass-premium segment
3.39x debt/equity ratio with negative net margins creates covenant breach risk and refinancing pressure, particularly if EBITDA deteriorates further
Near-zero reported operating cash flow and free cash flow suggest working capital strain and potential liquidity crisis without asset monetization or equity injection
License minimum guarantee obligations represent off-balance-sheet commitments that could accelerate cash burn if sales underperform
moderate-to-high - Fragrance purchases are discretionary, particularly in the mass-premium segment where Jacques Bogart competes. European consumer spending weakness directly impacts perfumery traffic and basket sizes. However, fragrances have lower ticket prices than luxury goods, providing some resilience versus high-end cosmetics. The company's exposure to French and Southern European markets increases sensitivity to Eurozone GDP growth and employment trends.
Rising interest rates negatively impact Jacques Bogart through two channels: (1) increased debt service costs on the company's 3.39x leverage ratio, compressing already thin 3.0% operating margins, and (2) reduced consumer discretionary spending as European households face higher mortgage and credit costs. The company's distressed valuation (0.2x sales) suggests refinancing risk if rates remain elevated, potentially forcing dilutive equity raises or asset sales.
High exposure - The company's negative net margin and 3.39x debt/equity ratio create refinancing risk in a higher-rate environment. Access to working capital facilities is critical for seasonal inventory builds ahead of holiday selling periods. Tightening credit conditions in European banking could restrict liquidity and force operational constraints.
value/distressed - The 0.2x sales and 0.7x book value multiples attract deep-value investors betting on turnaround execution or liquidation value exceeding market cap. The 41% one-year decline and negative momentum deter growth investors. Minimal institutional ownership likely given micro-cap size and liquidity constraints. Special situations funds may monitor for restructuring catalysts or acquisition by larger beauty conglomerates seeking European distribution assets.
high - The stock exhibits elevated volatility driven by low float, minimal analyst coverage, and binary outcomes around debt refinancing and license renewals. The -25.9% three-month return demonstrates sharp downside risk. Beta likely exceeds 1.5x relative to European small-cap indices given financial leverage and operational challenges.